¡°	micronize drospirenone	21.152672233611195
¡°	isolated drospirenone	17.90175229162925
¡°	micronized drospirenone particle	13.930747952400937
	isomerize	13.880757391696784
¡°	drospirenone molecular structure	8.940330299867185
¡°	unprotected normal drospirenone	6.09612964355649
	enteric coated tablet	5.130056549655248
	Tack	4.925129153702729
	micronization	4.7257641336905385
	enteric coating	4.441399744779351
	enteric coated pill	3.737649868717429
	micronized progestin	3.664745877659822
	contraceptive quality	3.47071912546344
	contraceptive function	3.44576247299783
	consume spirorenone metabolize	2.8102958404432785
	daily oral contraceptive	2.6055175791396197
	effective oral contraceptive	2.5910506385650747
	enteric coat formulation	2.5846059597975017
	progestogenic contraceptive effect	2.396463409884291
	Krause I	2.3804311027158342
	commercially available oral contraceptive	2.0742012733636623
	vitro isomerization study	2.039511801466099
	normal pill	1.9844328456476175
	Nickisch reference	1.914401874766141
	Robert Aulton treatise	1.8647165756073598
	vitro testing	1.761872153269197
	increase isomerization	1.2391803325254525
¡°	Yasmin success	1.098899701068243
	immediate release pill	0.9523926758768136
	ovulation	0.9488197790796387
	vivo study	0.8881274768682706
	increase bioavailability	0.8588245073547996
	Dosage Form Design	0.8325628541181253
	vivo condition	0.807849364984782
	diuretic effect	0.7896910481518363
	expert	0.753962594620392
	stomach acid	0.6682163769881666
	woman	0.5975672365347582
	ph acidic solution	0.5805983517531017
	high bioavailability	0.5686803702844311
	highly acidic gastric environment	0.5642014439723676
	progestogenic efficacy	0.5590139035256109
	poorly soluble drug	0.5479177134315544
	dissolution rate	0.488532293193012
	ph sensitive film	0.4811899986480392
	beagle	0.4746404094446854
	scientist	0.4513391196132447
	absolute bioavailability	0.4424237387572367
	stomach highly acidic environment	0.4360661094700054
	ph highly acidic environment	0.4357354322535412
	even low bioavailability	0.42681897904669996
	poorly water soluble hydrophobic composition	0.383536595369716
	drug exhibit bioavailability	0.38245186672945636
	assume gastric juice volume	0.37830848185170224
	less acidic duodenum small intestine	0.37465536069652955
	prior art progestin	0.35563475126584587
	human stomach	0.34418300480767927
	poorly water soluble drug	0.3375029039957636
	intravenous delivery	0.3200023362989574
	poorly water soluble composition	0.30096991888257196
	intravenous injection	0.2968699992849401
	absorption	0.2793432940117045
	acid sensitive composition	0.2586195009553465
	tack	0.2507364944149746
	single dose-"one dose	0.23981705298709552
	De Castro reference	0.23503758133534913
	intra inter individual bioavailability difference	0.22711442768916484
	estrogen component	0.2206172023398246
	bioavailability"-the amount	0.20577109400898502
	solubility	0.20289010140116784
	acid sensitivity problem	0.20191110693736386
	excess water retention	0.18965933751179678
	oral contraception	0.17687075946770792
	theory	0.16097781026841138
	anti acne quality	0.15494655872892277
	pharmaceutical producer	0.14371106930312832
	drawback	0.12443682587585991
	pH	0.12443682587585991
	Science	0.11724444577636413
	good chance	0.10935082819415655
	human female	0.10612907336609012
	pharmaceutical formulation	0.1017247316549906
	Owner	0.1014943437358942
	placebo	0.09972477862383823
	desirable anti bloating effect	0.09503764160142592
	clinical study	0.09374896278834234
	Takeda	0.08875965746256718
	invalidated	0.08357883147165819
	study shortcoming	0.08015253740881119
	drug particle size	0.07768080867755073
	active drug	0.07659611057223724
	innovation	0.07520936452662352
	mg	0.07481907781424059
	plan study	0.07441879864240658
	fast rate	0.06989149862446943
	complication	0.06646126981810985
	alleging	0.062248645407673116
	Forest Labs.	0.06023878682860873
	result isomer	0.05218531429613499
	Mayer	0.05057622340655033
	unchanged active substance	0.04854857726700685
	generic pharmaceutical	0.04693535320849225
	liquid	0.04683381919595595
	exposure	0.045864702188604174
	New Jersey	0.045241804057756
	one pharmaceutically acceptable carrier	0.04139127648530519
	oral dose form	0.039818516311222754
	clear skin	0.0391546578056793
	pharmaceutical composition	0.0353527020267494
	D.N.J. March	0.03410995624985822
	desirable quality	0.03356493300530888
	molecular composition	0.025735116287792556
	large pharmaceutical company	0.024051338870930077
	one method pharmaceutical company	0.023098337335101332
	KSR International Co.	0.020293336513381124
	active ingredient	0.01659938767109623
	protection	0.016415556492589443
	belief	0.016384263744959777
	therapeutic response	0.013770608604481233
	half	0.012594326108781083
	give volume	0.011810510804433098
	oral dosage form	0.011577846067973635
	III	0.01044143375565307
	observation	0.010110887307526734
	passage	0.009245592053448708
	considerable patient patient variation	0.009190611000579375
	approval	0.00871056494367331
	Food Drug Administration	0.007632414994450351
	Abbreviated New Drug Application	0.007176737246597916
	first choice	0.00623783753890014
	significant delay	0.005587393181338128
	Teleflex Inc.	0.005220716877826535
	unenforceability argument	0.0052193748475498035
	overall surface area	0.004748448450709652
	adverse ruling	0.004634776140562209
	definite firm conviction	0.004436972213397751
	large surface area	0.004336579478094662
	work	0.0041682473554750556
	sic	0.003988670133478599
	another piece	0.003655445982199183
	non routine element	0.0023551041298320737
	generic version	0.002337404832385495
	Chem	0.002259977354552106
	relate compound	0.0020495648051778426
	clear reduction	0.0019444329428806517
	three article	0.0016769569819002144
	practice	0.0015008460942375033
	little information	0.0014386482375171137
	sole issue	0.0011970062244267602
	critical conclusion	0.0011718828124527008
	five year	0.0009768521835752508
	September	0.0008355250136804778
	Indus	0.0006521884722140724
	content	0.00045960863187997675
	owner	0.000218637359099334
	obviousness rejection	0.000178917511847171
	ordinary skill	0.00015467545696871808
	examiner	0.00011161321681832187
	underlie fact	9.081854667108707e-05
	background	7.895130133885054e-05
	response time	7.17271618593597e-05
	combination	6.617218235881651e-05
	Trademark Office	6.031080964612508e-05
	specific reason	5.3154498188848484e-05
	addition	4.321432793052076e-05
	de novo	4.1390430257958244e-05
	jurisdiction	3.348340572968362e-05
	view	3.3233344924475414e-05
	different way	2.251686971384155e-05
	Claim	1.2597432448427372e-05
	clear error	1.2183577435374569e-05
	Ltd.	1.2109110954452857e-05
	different time	9.231965361298678e-06
	prosecution	6.659581420625633e-06
	trial	3.914527944927658e-06
	district court finding	2.1309721085663055e-06
	support evidence	1.6890075061322286e-06
	law	1.262364828136063e-07
	action	1.1981392297079664e-07
	two party	4.9390869259420294e-08
	District	0.0
	Court	0.0
	Appeals	0.0
